183 related articles for article (PubMed ID: 15491324)
1. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
4. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
Folpe AL; Chand EM; Goldblum JR; Weiss SW
Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
7. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
8. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin as a marker of vascular and lymphatic tumours.
Appleton MA; Attanoos RL; Jasani B
Histopathology; 1996 Aug; 29(2):153-7. PubMed ID: 8872149
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of ERG, Fli-1, CD34, CD31 and FⅧRAg expression in hepatic malignant vascular tumors].
Wang ZB; An XJ; Deng JF; Liu JH; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):760-763. PubMed ID: 29136688
[No Abstract] [Full Text] [Related]
11. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
Niemir ZI; Kubiak A; Olejniczak P; Nowak A; Czekalski S
Rocz Akad Med Bialymst; 2004; 49():213-8. PubMed ID: 15631346
[TBL] [Abstract][Full Text] [Related]
12. Comparison of CD34, CD31, and factor VIII-related antigen immunohistochemical expression in feline vascular neoplasms and CD34 expression in feline nonvascular neoplasms.
Jennings RN; Miller MA; Ramos-Vara JA
Vet Pathol; 2012 May; 49(3):532-7. PubMed ID: 22262349
[TBL] [Abstract][Full Text] [Related]
13. Angiostatin receptor annexin II in vascular tumors including angiosarcoma.
Syed SP; Martin AM; Haupt HM; Arenas-Elliot CP; Brooks JJ
Hum Pathol; 2007 Mar; 38(3):508-13. PubMed ID: 17239928
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of human hemangiosarcomas and hemangiomas.
Liu L; Kakiuchi-Kiyota S; Arnold LL; Johansson SL; Wert D; Cohen SM
Hum Pathol; 2013 Oct; 44(10):2302-11. PubMed ID: 24054722
[TBL] [Abstract][Full Text] [Related]
15. Assessment of angiogenic markers in oral hemangiomas and pyogenic granulomas.
Freitas TM; Miguel MC; Silveira EJ; Freitas RA; Galvão HC
Exp Mol Pathol; 2005 Aug; 79(1):79-85. PubMed ID: 16005715
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy.
Arbiser JL; Weiss SW; Arbiser ZK; Bravo F; Govindajaran B; Caceres-Rios H; Cotsonis G; Recavarren S; Swerlick RA; Cohen C
J Am Acad Dermatol; 2001 Feb; 44(2):193-7. PubMed ID: 11174372
[TBL] [Abstract][Full Text] [Related]
17. Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays.
Higgins JP; Montgomery K; Wang L; Domanay E; Warnke RA; Brooks JD; van de Rijn M
Am J Surg Pathol; 2003 Jan; 27(1):58-64. PubMed ID: 12502928
[TBL] [Abstract][Full Text] [Related]
18. Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangiodermatitis).
Kanitakis J; Narvaez D; Claudy A
Br J Dermatol; 1996 Jan; 134(1):44-6. PubMed ID: 8745885
[TBL] [Abstract][Full Text] [Related]
19. WT1 expression in angiogenic tumours of the skin.
Timár J; Mészáros L; Orosz Z; Albini A; Rásó E
Histopathology; 2005 Jul; 47(1):67-73. PubMed ID: 15982325
[TBL] [Abstract][Full Text] [Related]
20. Ulex europeus I--peroxidase as a marker of vascular endothelium: its application in routine histopathology.
Walker RA
J Pathol; 1985 Jun; 146(2):123-7. PubMed ID: 3891939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]